Melissa Papargiris

Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer

Matthew J. Watt, Ashlee K. Clark, Luke A. Selth et al. · Science Translational Medicine · 2019 · 314 citations

Medicine, Oncology, Urology +13

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories

Renea A. Taylor, Michael Fraser, Julie Livingstone et al. · Nature Communications · 2017 · 232 citations · Full text

Medicine, Genetics, Oncology +17

Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

Gail P. Risbridger, Renea A. Taylor, David Clouston et al. · European Urology · 2014 · 137 citations

Medicine, Oncology, Urology +16

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

Mitchell G. Lawrence, Daisuke Obinata, Shahneen Sandhu et al. · European Urology · 2018 · 119 citations · Full text

Medicine, Oncology, Urology +14

A preclinical xenograft model of prostate cancer using human tumors

Mitchell G. Lawrence, Renea A. Taylor, Roxanne Toivanen et al. · Nature Protocols · 2013 · 109 citations

Medicine, Biomedical Sciences, Oncology +8